Spots Global Cancer Trial Database for braf v600e negative
Every month we try and update this database with for braf v600e negative cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer | NCT04117945 | BRAF V600E Nega... KRAS Gene Mutat... Locally Advance... Metastatic Colo... NRAS Gene Mutat... Stage III Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... Stage IVC Color... | Cetuximab Irinotecan Panitumumab Regorafenib | 18 Years - | Academic and Community Cancer Research United |